In the evaluation of children with SS associated with growth hormone deficiency (GHD), data from several growth hormone (GH) surveillance programs have highlighted gender, racial and ethnic disparities in diagnosis and treatment (Table 1). The gene discussed is GH1; the disease is synovial sarcoma.